Publications by authors named "J Janik"

Claim this Profile
F
First-in-Human Phase I/II Study of INCAGN01876, a Glucocorticoid-Induced Tumor Necrosis Factor Receptor Agonist, in Patients with Advanced or Metastatic Solid Tumors.
Omid Hamid, Dana B Cardin, F Stephen Hodi, Patricia LoRusso, Taha Merghoub, John E Janik

Clin Cancer Res· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Establishment of Coala: a novel 3D and 2D cancer cell line derived from colorectal cancer liver metastasis.
Sandra Mersakova, Juraj Marcinek, Dusan Brany, Olga Chodelkova, Martin Vorcak, Jan Janik

Hum Cell· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-in-human phase I open-label study of the anti-TIM-3 monoclonal antibody INCAGN02390 in patients with select advanced or metastatic solid tumors.
Martin E Gutierrez, Shou-Ching Tang, John D Powderly, Ani S Balmanoukian, Paul E Hoyle, John E Janik

Oncologist· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
First-in-human phase I open-label study of the LAG-3 antagonist antibody INCAGN02385 in patients with select advanced or metastatic solid tumors.
John D Powderly, Martin E Gutierrez, Ani S Balmanoukian, Paul E Hoyle, Zhiwan Dong, John E Janik

Oncologist· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis Strategy Toward Minimizing Adventitious Oxygen Contents in the Mechanochemically Made Semiconductor Kesterite CuZnSnS Nanopowders.
Katarzyna Kapusta, Zbigniew Olejniczak, Jerzy F Janik

Materials (Basel)· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis